Ekso Bionics receives $700K from Parker-Hannifin; Nasdaq gives bid price deficiency notice

EKSO BIONICS HOLDINGS, INC.

Received $700,000 from Parker-Hannifin in settlement of warranty obligations under Asset Purchase Agreement.
Nasdaq notified Ekso that common stock bid price below $1.00 for 30 consecutive business days.
Company has 180 days, until March 27, 2024, to regain compliance by closing at $1.00 for 10 consecutive days.
If not compliant, may seek second 180-day period via reverse stock split or other cure.
Notice has no immediate effect on listing; company intends to monitor and consider options.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.